These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25219545)

  • 1. Detection of tetracosactide in plasma by enzyme-linked immunosorbent assay (ELISA).
    Martin L; Chaabo A; Lasne F
    Drug Test Anal; 2015 Jun; 7(6):531-4. PubMed ID: 25219545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification and qualification of synacthen in plasma.
    Chaabo A; de Ceaurriz J; Buisson C; Tabet JC; Lasne F
    Anal Bioanal Chem; 2011 Feb; 399(5):1835-43. PubMed ID: 21170520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of Synacthen(®) in dried blood spots for doping control analysis using liquid chromatography tandem mass spectrometry.
    Tretzel L; Thomas A; Geyer H; Delahaut P; Schänzer W; Thevis M
    Anal Bioanal Chem; 2015 Jun; 407(16):4709-20. PubMed ID: 25863802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assays for doping control of 5alpha-reductase inhibitors finasteride and dutasteride.
    Brun EM; Torres A; Ventura R; Puchades R; Maquieira A
    Anal Chim Acta; 2010 Jun; 671(1-2):70-9. PubMed ID: 20541645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sports doping: emerging designer and therapeutic β2-agonists.
    Fragkaki AG; Georgakopoulos C; Sterk S; Nielen MW
    Clin Chim Acta; 2013 Oct; 425():242-58. PubMed ID: 23954776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous and tetracosactide-induced anti-ACTH antibodies in man.
    Gan EH; MacArthur K; Mitchell AL; Joshi A; Crock P; Pearce SH
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):489-95. PubMed ID: 25880719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immunoassays for the measurement of erythropoietin (EPO) as an indirect biomarker of recombinant human EPO misuse in sport.
    Abellan R; Ventura R; Pichini S; Remacha AF; Pascual JA; Pacifici R; Di Giovannandrea R; Zuccaro P; Segura J
    J Pharm Biomed Anal; 2004 Sep; 35(5):1169-77. PubMed ID: 15336362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Synacthen in human plasma using immunoaffinity purification and liquid chromatography/tandem mass spectrometry.
    Thevis M; Bredehöft M; Geyer H; Kamber M; Delahaut P; Schänzer W
    Rapid Commun Mass Spectrom; 2006; 20(23):3551-6. PubMed ID: 17099925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine analysis concerning xenon for doping control purposes.
    Thevis M; Piper T; Geyer H; Schaefer MS; Schneemann J; Kienbaum P; Schänzer W
    Rapid Commun Mass Spectrom; 2015 Jan; 29(1):61-6. PubMed ID: 25462364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of luteinizing hormone (LH): Validation of a commercial ELISA kit for LH analysis and quantification in doping control samples.
    Mäkelä R; Leinonen A; Suominen T
    Drug Test Anal; 2020 Feb; 12(2):239-246. PubMed ID: 31655497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Application of the ultra micro analytical system (SUMA) technology for the detection of urinary hCG in antidoping control".
    Martinez Brito D; Bueno Fis E; Fiallo Fernandez T; Torres Castellanos M; Correa Vidal MT; Montes De Oca Porto R
    J Immunoassay Immunochem; 2018; 39(6):672-686. PubMed ID: 30346873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes.
    Thomas A; Solymos E; Schänzer W; Baume N; Saugy M; Dellanna F; Thevis M
    Anal Chim Acta; 2011 Nov; 707(1-2):107-13. PubMed ID: 22027126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
    Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
    Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls.
    Thomas A; Schänzer W; Delahaut P; Thevis M
    Methods; 2012 Feb; 56(2):230-5. PubMed ID: 21871962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) for the detection of phenylethanolamine A in tissue and feed samples and confirmed by liquid chromatography tandem mass spectrometry (LC-MS/MS).
    Cao B; He G; Yang H; Chang H; Li S; Deng A
    Talanta; 2013 Oct; 115():624-30. PubMed ID: 24054641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doping control analysis of desmopressin in human urine by LC-ESI-MS/MS after urine delipidation.
    Esposito S; Deventer K; T'Sjoen G; Vantilborgh A; Van Eenoo P
    Biomed Chromatogr; 2013 Feb; 27(2):240-5. PubMed ID: 22740500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
    Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of autologous blood transfusions in athletes: a historical perspective.
    Mørkeberg J
    Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.